Zymeworks Inc
NYSE:ZYME
Zymeworks Inc
Common Stock
Zymeworks Inc
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zymeworks Inc
NYSE:ZYME
|
Common Stock
$1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Common Stock
$363.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Common Stock
$483.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Common Stock
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Common Stock
$1.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
17%
|
|
Spectral Medical Inc
TSX:EDT
|
Common Stock
CA$87.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
See Also
What is Zymeworks Inc's Common Stock?
Common Stock
1B
USD
Based on the financial report for Dec 31, 2023, Zymeworks Inc's Common Stock amounts to 1B USD.
What is Zymeworks Inc's Common Stock growth rate?
Common Stock CAGR 5Y
26%
Over the last year, the Common Stock growth was 11%. The average annual Common Stock growth rates for Zymeworks Inc have been 12% over the past three years , 26% over the past five years .